Registered entities
Alnylam Pharmaceuticals, Inc.
Reg. No. 1178670United States
Social engagement
Social engagement: 290.2K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
15 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 53% |
| Private equity | 5 | 33% |
| Other / undisclosed | 2 | 13% |
Hiring activity
Hires periodically
16 roles tracked across 5 of the last 12 months
5 Apr 2026 · Director, Regulatory Affairs for U.S. Advertising and Promotion (USAP) · Cambridge
26 Mar 2026 · Associate Director, Content Enablement Platforms · Cambridge
26 Mar 2026 · Director, Financial Planning & Analysis, Business Development · Cambridge
10 Mar 2026 · Director, Clinical Operations · Cambridge
2 Mar 2026 · Manager, Manufacturing Systems · Cambridge
Based on job postings tracked across public sources.
Recent activity
25 Jun 2026
Event
RNAi Roundtable webinars
22 Jun 2026
Event
RNAi Roundtable webinars